"Das Knappschaftskrankenhaus Bochum wurde 1909 als Gemeindekrankenhaus gegründet und ist seit 1977 Universitätsklinik der Ruhr-Universität Bochum. Heute verfügt das Universitätsklinikum über 479 Betten und neun Fachabteilungen. Jedes Jahr werden 22.000 stationäre sowie ca. 50.000 ambulante Patienten behandelt. Den hohen Standard der Patientenversorgung stellen 1600 hochqualifizierte und motivierte Mitarbeiter sicher. Durch die moderne apparative und technische Ausstattung sind innovative Diagnose- und Therapieverfahren etabliert. (Stand: 2019)"

During the past decade, Knappschaftskrankenhaus Bochum-Langendreer conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 4 clinical trials were completed, i.e. on average, 16% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Knappschaftskrankenhaus Bochum-Langendreer" #1 sponsor was "University of Ulm" with 5 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Glaukos Corporation" with 2 trials sponsored and "Microvention-Terumo, Inc." with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Knappschaftskrankenhaus Bochum-Langendreer" #1 collaborator was "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Biotest" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Eppdata Hamburg" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Knappschaftskrankenhaus Bochum-Langendreer" are "Acute Myeloid Leukemia" (3 trials), "Intracranial Aneurysm" (3 trials), "Lymphoma" (3 trials), "Acute Myeloid Leukemia (AML)" (2 trials) and "Complications" (2 trials). Many other conditions were trialed in "Knappschaftskrankenhaus Bochum-Langendreer" in a lesser frequency.

Most popular intervention types in "Knappschaftskrankenhaus Bochum-Langendreer" are "Drug" (26 trials), "Device" (10 trials), "Procedure" (7 trials), "Biological" (5 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (4 trials), "radiation therapy" (4 trials), "Cytarabine" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Knappschaftskrankenhaus Bochum-Langendreer" are 41 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Knappschaftskrankenhaus Bochum-Langendreer". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Knappschaftskrankenhaus Bochum-Langendreer, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Knappschaftskrankenhaus Bochum-Langendreer, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".

Knappschaftskrankenhaus Bochum-Langendreer has several departments that took part in Clinical trials: "Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic" - 2 trials, "Department of Pain Medicine" - 2 trials